Tryptophan hydroxylase 2 (TPH2) gene polymorphisms and psychiatric comorbidities in temporal lobe epilepsy

Epilepsy and Behavior

Volumn 32, Issue , 2014, Pages 59-63

  Bragatti, José Augusto ^a,b   Bandeira, Isabel Cristina ^a,b   de Carvalho, Agata Mantese ^b   Abujamra, Ana Lúcia ^a,b   Leistner Segal, Sandra ^b   Bianchin, Marino Muxfeldt ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

5 HTT; Alcohol abuse; Epilepsy; Serotonergic system; TPH2

Indexed keywords

ANTICONVULSIVE AGENT; TRYPTOPHAN HYDROXYLASE 2; SEROTONIN; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; TRYPTOPHAN HYDROXYLASE;

ADULT; ALCOHOL ABUSE; ALLELE; ANTICONVULSANT THERAPY; ANXIETY DISORDER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PSYCHOSIS; SEROTONINERGIC SYSTEM; TEMPORAL LOBE EPILEPSY; COMORBIDITY; EPILEPSY, TEMPORAL LOBE; GENETIC POLYMORPHISM; GENETICS; MENTAL DISORDERS; METABOLISM; MIDDLE AGED; PSYCHOLOGY; SEX DIFFERENCE;

ADULT; ALLELES; COHORT STUDIES; COMORBIDITY; EPILEPSY, TEMPORAL LOBE; FEMALE; GENOTYPE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGENTS; SEROTONIN RECEPTOR AGONISTS; SEX FACTORS; TRYPTOPHAN HYDROXYLASE;

EID: 84893349019     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2014.01.007     Document Type: Article

References (45)

1. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 1985, 26:268-278.
2. Schmitz B., Wolff P. Psychosis with epilepsy: frequency and risk factors. J Epilepsy 1995, 8:295-305.
3. Schmitz B. Effects of antiepileptic drugs on mood and behavior. Epilepsia 2006, 47(Suppl. 2):S28-S33.
4. Bragatti J.A., Torres C.M., Londero R.G., Assmann J.B., Fontana V., Martin K.C., et al. Prevalence of psychiatric comorbidities in temporal lobe epilepsy: the value of structured psychiatric interviews. Epileptic Disord 2010, 12:283-291.
5. Dalmagro C.L., Velasco T.R., Bianchin M.M., Martins A.P., Guarnieri R., Cescato M.P., et al. Psychiatric comorbidity in refractory focal epilepsy: a study of 490 patients. Epilepsy Behav 2012, 25:593-597.
6. Torta R., Keller R. Behavioral, psychotic, and anxiety disorders in epilepsy: etiology, clinical features, and therapeutic implications. Epilepsia 1999, 40(Suppl. 10):S2-S20.
7. Devinsky O. Psychiatric comorbidity in patients with epilepsy: implications for diagnosis and treatment. Epilepsy Behav 2003, 4(Suppl. 4):S2-S10.
8. Dudra-Jastrzebska M., Andres-Mach M.M., Tuszczki J.J., Czuczwar S.J. Mood disorders in patients with epilepsy. Pharmacol Rep 2007, 59:369-378.
9. Hecimovic H., Salpekar J., Kanner A.M., Barry J.J. Suicidality and epilepsy: a neuropsychobiological perspective. Epilepsy Behav 2011, 22:77-84.
10. Kurian M.A., Gissen P., Smith M., Heales S., Clayton P.T. The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. Lancet Neurol 2011, 10:721-733.
11. Richerson G.B., Buchanan G.F. The serotonin axis: shared mechanisms in seizures, depression, and SUDEP. Epilepsia 2011, 52(Suppl. 1):28-38.
12. Werner F.M., Coveñas R. Classical neurotransmitters and neuropeptides involved in generalized epilepsy: a focus on antiepileptic drugs. Curr Med Chem 2011, 18:4933-4948.
13. Bagdy G., Kecskemeti V., Riba P., Jakus R. Serotonin and epilepsy. J Neurochem 2007, 100:857-873.
14. Ruhe H.G., Mason N.S., Schene A.H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 2007, 12:331-359.
15. Blier P., El Mansari M. Serotonin and beyond: therapeutics for major depression. Philos Trans R Soc Lond B Biol Sci 2013, 368:20120536.
16. Stahl S.M., Lee-Zimmerman C., Cartwright S., Morrissette D.A. Serotonergic drugs for depression and beyond. Curr Drug Targets 2013, 14:578-585.
17. Lesch K.P., Mossner R. Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders?. Biol Psychiatry 1998, 44:179-192.
18. Stefulj J., Bordukalo-Niksic T., Hecimovic H., Demarin V., Jernej B. Epilepsy and serotonin (5HT): variations of 5HT-related genes in temporal lobe epilepsy. Neurosci Lett 2010, 478:29-31.
19. Schenkel L.C., Bragatti J.A., Becker J.A., Torres C.M., Martin K.C., de Souza A.C., et al. Serotonin gene polymorphisms and psychiatry comorbidities in temporal lobe epilepsy. Epilepsy Res 2012, 99:260-266.
20. Gao J., Pan Z., Jiao Z., Li F., Zhao G., Wei Q., et al. TPH2 gene polymorphisms and major depression-a meta-analysis. PLoS One 2012, 7:e36721.
21. Serretti A., Chiesa A., Porcelli S., Han C., Patkar A.A., Lee S.J., et al. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Psychiatry Res 2011, 189:26-32.
22. Pregelj P. Single nucleotide polymorphisms and suicidal behaviour. Psychiatr Danub 2012, 24(Suppl. 1):S61-S64.
23. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399.
24. First M., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for Axis I DSM-IV-TR disorders: non-patient edition 2001, New York State Psychiatric Institute, Biometrics Research Department.
25. American Psychiatric Association (APA) Diagnostic and statistical manual of mental disorders IV 2000, American Psychiatric Press, Washington.
26. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1998, 1215:16.
27. Van Guilder H.D., Vrana K.E., Freeman W.M. Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 2008, 44:619-626.
28. Stevens J. Applied multivariate statistic for the social sciences 1996, Lawrence Erlbaum, Rahway, New Jersey. 3rd ed.
29. Hosmer D., Lemeshow S. Applied logistic regression 1989, John Wiley and Sons, Inc.
30. Tabachnick B., Fidell L. Using multivariate statistics 1996, Harper Collins. 3rd ed.
31. Walther D.J., Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 2003, 66:1673-1680.
32. Invernizzi R.W. Role of TPH-2 in brain function: news from behavioral and pharmacologic studies. J Neurosci Res 2007, 85:3030-3035.
33. Patel P.D., Pontrello C., Burke S. Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal gland. Biol Psychiatry 2004, 55:428-433.
34. Zill P., Buttner A., Eisenmenger W., Moller H.J., Ackenheil M., Bondy B. Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a postmortem study. J Psychiatr Res 2007, 41:168-173.
35. Morissette J., Villeneuve A., Bordeleau L., Rochette D., Laberge C., Gagne B., et al. Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in Quebec points to a locus of major effect on chromosome 12q23-q24. Am J Med Genet 1999, 88:567-587.
36. Abkevich V., Camp N.J., Hensel C.H., Neff C.D., Russell D.L., Hughes D.C., et al. Predisposition locus for major depression at chromosome 12q22-12q23.2. Am J Hum Genet 2003, 73:1271-1281.
37. Curtis D., Kalsi G., Brynjolfsson J., McInnis M., O'Neill J., Smyth C., et al. Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23-q24, and suggests the presence of additional loci on 1p and 1q. Psychiatr Genet 2003, 13:77-84.
38. Moncrieff J. A critique of the dopamine hypothesis of schizophrenia and psychosis. Harv Rev Psychiatry 2009, 17:214-225.
39. Owen M.J., Craddock N., Jablensky A. The genetic deconstruction of psychosis. Schizophr Bull 2007, 33:905-911.
40. Sumiyoshi T., Higuchi Y., Uehara T. Neural basis for the ability of atypical antipsychotic drugs to improve cognition in schizophrenia. Front Behav Neurosci 2013, 7:140.
41. Rietschel M., Treutlein J. The genetics of alcohol dependence. Ann N Y Acad Sci 2013, 1282:39-70.
42. Sari Y., Johnson V.R., Weedman J.M. Role of the serotonergic system in alcohol dependence: from animal models to clinics. Prog Mol Biol Transl Sci 2011, 98:401-443.
43. LeMarquand D., Pihl R.O., Benkelfat C. Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biol Psychiatry 1994, 36:395-421.
44. Mukherjee S., Das S.K., Vaidyanathan K., Vasudevan D.M. Consequences of alcohol consumption on neurotransmitters-an overview. Curr Neurovasc Res 2008, 5:266-272.
45. Cordeiro Q., Souza B.R., Correa H., Guindalini C., Hutz M.H., Vallada H., et al. A review of psychiatric genetics research in the Brazilian population. Rev Bras Psiquiatr 2009, 415:1-9.